Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report

Small cell carcinoma of the urinary bladder is a rare subtype (incidence of 1–9/1,000,000), characterized by an aggressive behavior with early metastasis and poor prognosis. Chemotherapy, radiation, and surgery are the usual treatment options, but to date, no accepted standard treatment exists. Sinc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol
Autors principals: Nguyen, Olav Toai Duc, Sundstrøm, Stein Harald, Westvik, Ganna Surzhykova, Røttereng, Ane Karoline Stræte, Melhus, Mona Røli, Bergseth, Cecilie, Hallem, Elisabeth Kvelstad, Røe, Oluf Dimitri
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548951/
https://ncbi.nlm.nih.gov/pubmed/33082749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509747
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars